491000 — Livsmed Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩51bn
Annual cashflow statement for Livsmed, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -57,021 | -25,585 | -22,874 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 38,063 | 4,470 | 6,490 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -6,800 | -8,196 | -21,090 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Net Change in Other Assets & Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -24,723 | -27,664 | -34,740 |
| Capital Expenditures | -2,494 | -4,455 | -7,723 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -32,529 | 30,897 | -121,450 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -35,023 | 26,442 | -129,173 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 52,884 | 10,170 | 158,443 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -6,892 | 8,797 | -5,413 |